USPTO Examiner HEIN DEVIN C - Art Unit 3686

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18820440Production And Delivery Tracking And Sample Verification Of Patient-Specific TherapeuticsAugust 2024November 2025Allow1510NoNo
18813798SYSTEM AND METHOD FOR CREATION OF PERSISTENT PATIENT IDENTIFICATIONAugust 2024February 2025Allow610YesNo
18805697SYSTEM AND METHOD FOR CREATION OF PERSISTENT PATIENT IDENTIFICATIONAugust 2024March 2025Allow710YesNo
18743729METHODS AND SYSTEMS FOR MANAGING PATIENT TREATMENT COMPLIANCEJune 2024November 2025Allow1710NoNo
18740246SYNTHESIZING COMPLEX POPULATION SELECTION CRITERIAJune 2024July 2025Abandon1310YesNo
18734284DOSING OF INCRETIN PATHWAY DRUGSJune 2024October 2025Allow1600YesNo
18672436SYSTEMS AND METHODS FOR DISPENSING A STATIN MEDICATION OVER THE COUNTERMay 2024July 2025Allow1400YesNo
18649982SYSTEMS AND METHODS FOR PREDICTING PATIENT OUTCOME TO CANCER THERAPYApril 2024September 2025Allow1710YesNo
18625041METHOD AND SYSTEM FOR AUTOMATED DIFFERENTIAL MEDICAL DIAGNOSIS ASSESMENTApril 2024March 2026Allow2310YesNo
18617468SYSTEMS AND METHODS FOR DISPENSING A STATIN MEDICATION OVER THE COUNTERMarch 2024July 2025Allow1510NoNo
18586281System and Method for Advanced Identification of a CustomerFebruary 2024September 2024Allow700YesNo
18442432SYSTEMS AND METHODS FOR PRE-OPERATIVE PROCEDURE DETERMINATION AND OUTCOME PREDICTINGFebruary 2024January 2025Allow1110YesNo
18527160DECISION SUPPORT SYSTEMS FOR DETERMINING CONFORMITY WITH MEDICAL CARE QUALITY STANDARDSDecember 2023July 2025Allow2020YesNo
18523564Production And Delivery Tracking And Sample Verification Of Patient-Specific TherapeuticsNovember 2023June 2024Allow700YesNo
18501103METHOD AND SYSTEM TO FACILITATE PATIENT CARENovember 2023November 2024Abandon1310NoNo
18483142Order StatusOctober 2023September 2025Abandon2440YesNo
18374767LABELING APPARATUSSeptember 2023July 2024Allow910YesNo
18468055METHODS AND SYSTEMS FOR MANAGING PATIENT TREATMENT COMPLIANCESeptember 2023June 2024Allow910YesNo
18272692METHOD AND APPARATUS FOR PROCESSING SAMPLEJuly 2023October 2025Abandon2710NoNo
18352216SYSTEM FOR PREDICTING END-STAGE RENAL DISEASE COMPLICATION RISK BASED ON CONTRASTIVE LEARNINGJuly 2023November 2023Allow400NoNo
18128042SYSTEM AND METHOD FOR ADVANCED IDENTIFICATION OF A CUSTOMERMarch 2023November 2023Allow700YesNo
18190778DETERMINATION OF PERSONALIZED ENDOCANNABINOID GENOTYPES AND ASSOCIATED RECOMMENDATIONSMarch 2023October 2023Allow700YesNo
18044722OPTIMIZATION SYSTEM AND METHOD FOR MEDICAL SYSTEM, AND COMPUTER-READABLE STORAGE MEDIUMMarch 2023September 2025Abandon3020YesNo
18181474HEALTH CARE DELIVERY SYSTEM AND METHODMarch 2023April 2024Abandon1310NoNo
18156259METHODS AND SYSTEMS FOR MANAGING PATIENT TREATMENT COMPLIANCEJanuary 2023August 2023Allow700YesNo
18096765AUTOMATED PHARMACY TRANSLATION ENGINE FOR PRESCRIPTION MEDICATION INSTRUCTIONSJanuary 2023June 2025Allow2950YesNo
18094472AUTOMATED INTERVENTION SYSTEM BASED ON CHANNEL-AGNOSTIC INTERVENTION MODELJanuary 2023July 2023Allow700YesNo
18092260CHANNEL-SPECIFIC ENGAGEMENT MACHINE LEARNING ARCHITECTUREDecember 2022July 2023Allow700YesNo
18014141LEARNING DATA GENERATION DEVICE, METHOD FOR DRIVING SAME DEVICE, AND COMPUTER-READABLE RECORDING MEDIUMDecember 2022January 2026Abandon3630NoYes
18001036MEDICAL INFORMATION SYSTEM, CHARGE CALCULATING DEVICE, AND CHARGE CALCULATING METHODDecember 2022August 2025Abandon3320NoNo
17992755SYSTEMS AND METHODS FOR USING MACHINE LEARNING ALGORITHMS TO IDENTIFY CARE GAPSNovember 2022January 2026Allow3810YesNo
18057048Multi-Dose Packaging Medication Administration SystemNovember 2022August 2023Allow900YesNo
17983002USING NATURAL LANGUAGE PROCESSING TO FIND ADVERSE EVENTSNovember 2022April 2024Allow1720NoNo
17978677ENCODED GRAPHICAL MODELING SYSTEM AND METHOD FOR MATCHING PATIENTS OR MEMBERS NEEDING A PARTICULAR MEDICAL PROCEDURE OR OTHER HEALTH INTERVENTION WITH HEALTHCARE FACILITIES OR PROVIDERSNovember 2022January 2026Allow3920NoNo
17971778SYSTEMS AND METHODS FOR PREDICTING PATIENT OUTCOME TO CANCER THERAPYOctober 2022December 2023Allow1410YesNo
17955144Order StatusSeptember 2022July 2023Allow900YesNo
17952307APPARATUS AND METHOD FOR PROVIDING PATIENT ADMINISTERED AND PHYSICIAN PRESCRIBED AND MONITORED DRUG TITRATIONSeptember 2022October 2025Abandon3760NoNo
17898115SYSTEMS AND METHODS FOR DISPENSING A STATIN MEDICATION OVER THE COUNTERAugust 2022January 2024Allow1720NoNo
17893925MEDICAL INCIDENT RESPONSE AND REPORTING SYSTEM AND METHODAugust 2022August 2024Allow2400YesNo
17866616METHOD AND SYSTEM TO FACILITATE PATIENT CAREJuly 2022July 2023Allow1200YesNo
17859910NON-TRANSITORY COMPUTER-READABLE STORAGE MEDIUM, INFORMATION PROCESSING APPARATUS, AND INFORMATION PROCESSING METHODJuly 2022February 2025Abandon3210NoNo
17855958SYSTEM AND METHOD FOR ADJUSTING HOSPITAL UNIT CAPACITY BASED ON PATIENT-SPECIFIC VARIABLESJuly 2022December 2025Abandon4220NoNo
17848993REMOTE MONITORING METHODS AND SYSTEMS FOR MONITORING PATIENTS SUFFERING FROM CHRONICAL INFLAMMATORY DISEASESJune 2022May 2025Abandon3420YesNo
17846355AUTOMATED CLINICAL DOCUMENTATION SYSTEM AND METHODJune 2022January 2024Allow1910YesNo
17804781DEVICE AND METHODS FOR MACHINE LEARNING-DRIVEN DIAGNOSTIC TESTINGMay 2022January 2025Allow3210NoNo
17756177DELIVERY MANAGEMENT SYSTEMMay 2022August 2024Allow2710YesNo
17743299SYSTEMS, DEVICES AND METHODS FOR DETECTING AND TRACKING DRUG EXTRACTIONMay 2022September 2024Allow2810YesNo
17731282CANCER TYPE PREDICTION SYSTEMApril 2022September 2025Abandon4120NoNo
17729335SYSTEM FOR DYNAMIC LOCATION-AWARE PATIENT CARE PROCESS CONTROLS AND DYNAMIC LOCATION-AWARE TRACKINGApril 2022September 2025Allow4150YesNo
17658140REDUCING INFUSION PUMP NETWORK CONGESTION BY STAGGERING UPDATESApril 2022August 2023Allow1710YesNo
17764468MRTHOD, DEVICE FOR DISEASE PREDICTION, ELECTRONIC DEVICE AND COMPUTER-READABLE STORAGE MEDIUMMarch 2022September 2025Abandon4220NoNo
17700558AI BASED SYSTEM AND METHOD FOR PREDICITING CONTINUOUS CARDIAC OUTPUT (CCO) OF PATIENTSMarch 2022August 2025Abandon4120YesNo
17696059SYNTHESIZING COMPLEX POPULATION SELECTION CRITERIAMarch 2022February 2024Allow2330YesNo
17696498MACHINE LEARNING METHOD FOR IDENTIFYING DRUG INTERACTIONSMarch 2022September 2025Abandon4230NoNo
17629047AUTOMATED CLINICAL DECISION DISAMBIGUATIONJanuary 2022January 2025Abandon3620NoNo
17566503ARTIFICIAL INTELLIGENCE-BASED MEDICAL CODING AND DIAGNOSISDecember 2021October 2025Allow4640YesNo
17619742DEVICE AT THE POINT OF IMAGING FOR INSTANT ADVICE ON CHOICES TO STREAMLINE IMAGING WORKFLOWDecember 2021December 2024Abandon3620NoNo
17644687METHODS, SYSTEMS, AND COMPUTER PROGRAM PRODUCTS USING ARTIFICIAL INTELLIGENCE FOR COORDINATED IDENTIFICATION OF PATIENTS FOR A CLINICAL TRIAL BASED ON SOCIAL DETERMINANTS OF HEALTH INFORMATIONDecember 2021October 2025Allow4630YesNo
17524352AI BASED CONTEXT AWARE MULTIDIRECTIONAL PATIENT MOVEMENTNovember 2021May 2025Allow4210YesNo
17519657SYSTEMS AND METHODS FOR PRE-OPERATIVE PROCEDURE DETERMINATION AND OUTCOME PREDICTINGNovember 2021November 2023Allow2420NoNo
17519873METHOD AND APPARATUS FOR ANALYZING MEDICAL TREATMENT DATA BASED ON DEEP LEARNINGNovember 2021May 2024Abandon3020YesNo
17514826DEVICES AND METHOD FOR A HEALTHCARE COLLABORATION SPACEOctober 2021November 2024Allow3710NoNo
17491661SYSTEM AND METHOD FOR INITIATING TELEMEDICINE CONFERENCE USING SELF-DIAGNOSTIC TESTOctober 2021February 2024Abandon2920NoNo
17491829System and Methods for Providing Inductive Sensing of Sharps and Other Medical InstrumentsOctober 2021March 2025Allow4130NoNo
17437964METHOD AND SYSTEM FOR PROVIDER NETWORK OPTIMIZATION BASED ON IDENTIFICATION OF HIGH-PRIORITY AREAS WITH TARGETED POPULATIONS BY A HEALTH ECONOMICS APPROACHSeptember 2021January 2025Abandon4110NoNo
17462931NETWORK USER DATA DELIVERYAugust 2021August 2025Allow4830YesNo
17461190System and Method for Creation of Persistent Patient IdentificationAugust 2021September 2024Allow3720YesNo
17384879UNIVERSAL PHYSICIAN RANKING SYSTEM BASED ON AN INTEGRATIVE MODEL OF PHYSICIAN EXPERTISEJuly 2021August 2023Abandon2540NoNo
17381956GEOLOCATION PATHOGEN-RISK ASSESSMENT WITH PANDEMIC-BIO-SURVEILLANCE MULTI PATHOGEN SYSTEMSJuly 2021July 2022Allow1120NoNo
17381932NATURAL-LANGUAGE TEXT GENERATION WITH PANDEMIC-BIO-SURVEILLANCE MULTI PATHOGEN SYSTEMSJuly 2021May 2025Abandon4630YesNo
17378245PREDICTING ADDICTION RELAPSE AND DECISION SUPPORT TOOLJuly 2021November 2023Allow2820YesNo
17419283PREDICTION OF USAGE OR COMPLIANCEJune 2021June 2025Allow4830YesNo
17323138SYSTEMS AND METHODS FOR DISPENSING A STATIN MEDICATION OVER THE COUNTERMay 2021December 2023Allow3120NoNo
17294514EMERGENCY DEMAND PREDICTION DEVICE, EMERGENCY DEMAND PREDICTION METHOD, AND PROGRAMMay 2021February 2024Allow3310YesNo
17221384SYSTEM AND METHOD FOR GENERATING A PROCREANT FUNCTIONAL PROGRAMApril 2021June 2024Allow3810YesNo
17218487METHODS, SYSTEMS, AND COMPUTER PROGRAM PRODUCTS USING ARTIFICIAL INTELLIGENCE FOR COORDINATED IDENTIFICATION OF PATIENTS FOR A CLINICAL TRIAL THAT ARE SERVED BY MULTIPLE PROVIDERSMarch 2021October 2025Allow5550YesNo
17206707LABELING APPARATUSMarch 2021May 2023Allow2610NoNo
17271144APHERESIS DEVICES FLEET MANAGEMENT SYSTEM AND METHODFebruary 2021December 2025Allow5850YesNo
17169640AUTOMATED PHARMACY TRANSLATION ENGINE FOR PRESCRIPTION MEDICATION INSTRUCTIONSFebruary 2021September 2022Allow2000YesNo
17248299Patient-Facing App for Health Literacy and NumeracyFebruary 2021July 2023Abandon3010NoNo
17161092METHODS AND SYSTEMS FOR MANAGING PATIENT TREATMENT COMPLIANCEJanuary 2021October 2022Allow2000YesNo
17154981SYSTEM AND METHOD FOR ON-DEMAND ONLINE CONSULTATIONJanuary 2021April 2023Abandon2710NoNo
17248295System For Interpreting And Managing Diet And Medication InteractionsJanuary 2021May 2023Abandon2710YesNo
17248300Patient-Facing App for Health Literacy and NumeracyJanuary 2021April 2023Abandon2710YesNo
17248297System For Interpreting And Managing Health InformationJanuary 2021June 2023Abandon2910NoNo
17137721EMR INTEGRATED ELECTRONIC CASE REPORTINGDecember 2020October 2024Abandon4610YesNo
17136199SYSTEM AND METHOD FOR GENERATING A PROCREANT NOURISHMENT PROGRAMDecember 2020February 2021Allow200NoNo
17132731SYSTEMS AND METHODS FOR DISPENSING A STATIN MEDICATION OVER THE COUNTERDecember 2020April 2022Allow1600NoNo
17118872SYSTEMS AND METHODS FOR PREDICTIVE ANOMALY DETECTION IN PHARMACEUTICAL PROCESSING DATADecember 2020February 2025Allow5020YesNo
17095504CHANNEL-SPECIFIC ENGAGEMENT MACHINE LEARNING ARCHITECTURENovember 2020November 2022Allow2510YesNo
17052464DISEASE NETWORK CONSTRUCTION METHOD CONSIDERING STRATIFICATION ACCORDING TO CONFOUNDING VARIABLE OF COHORT DATA AND OCCURRENCE TIME BETWEEN DISEASES, METHOD FOR VISUALIZING SAME, AND COMPUTER READABLE RECORDING MEDIUM RECORDING SAMENovember 2020July 2022Abandon2010NoNo
17074442METHODS AND SYSTEMS FOR MANAGING PATIENT TREATMENT COMPLIANCEOctober 2020January 2021Allow300NoNo
17068043REDUCING INFUSION PUMP NETWORK CONGESTION BY STAGGERING UPDATESOctober 2020January 2022Allow1500YesNo
17065447APPARATUS AND METHOD FOR PROVIDING PATIENT ADMINISTERED AND PHYSICIAN PRESCRIBED AND MONITORED DRUG TITRATIONOctober 2020September 2022Abandon2410NoNo
17061175Order StatusOctober 2020June 2022Allow2110YesNo
17035676HEALTH CARE DELIVERY SYSTEM AND METHODSeptember 2020June 2022Abandon2110NoNo
17005935PATIENT MANAGEMENT BASED ON SENSED INPUTSAugust 2020April 2025Allow5540YesNo
16939324Automated Healthcare Provider Quality Reporting System (PQRS)July 2020May 2022Abandon2110NoNo
16939244METHOD OF AND SYSTEM FOR GENERATING A STRESS BALANCE INSTRUCTION SET FOR A USERJuly 2020April 2024Allow4520YesNo
16940337FINGERPRINT ENHANCED AUTHENTICATION FOR MEDICAL DEVICES IN WIRELESS NETWORKSJuly 2020February 2022Allow1910YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner HEIN, DEVIN C.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
18
Examiner Affirmed
17
(94.4%)
Examiner Reversed
1
(5.6%)
Reversal Percentile
21.9%
Lower than average

What This Means

With a 5.6% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
29
Allowed After Appeal Filing
5
(17.2%)
Not Allowed After Appeal Filing
24
(82.8%)
Filing Benefit Percentile
20.9%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 17.2% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner HEIN, DEVIN C - Prosecution Strategy Guide

Executive Summary

Examiner HEIN, DEVIN C works in Art Unit 3686 and has examined 276 patent applications in our dataset. With an allowance rate of 46.0%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 40 months.

Allowance Patterns

Examiner HEIN, DEVIN C's allowance rate of 46.0% places them in the 10% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by HEIN, DEVIN C receive 2.67 office actions before reaching final disposition. This places the examiner in the 78% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by HEIN, DEVIN C is 40 months. This places the examiner in the 25% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +28.0% benefit to allowance rate for applications examined by HEIN, DEVIN C. This interview benefit is in the 75% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 14.2% of applications are subsequently allowed. This success rate is in the 10% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 11.6% of cases where such amendments are filed. This entry rate is in the 11% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 80.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 64% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 25.0% of appeals filed. This is in the 3% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 10.8% are granted (fully or in part). This grant rate is in the 8% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 40% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 43% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.